Join to View Full Profile
419 W Redwood StBaltimore, MD 21201
Phone+1 410-328-6425
Fax+1 410-328-0595
Dr. Phelan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Based in Baltimore, MD, Dr. Michael Phelan specializes in Urology with subspecialties in Minimally Invasive Surgery, Stone Disease, Kidney Transplantation, and Surgical Oncology. He completed his medical education at Boston University, followed by a residency in Surgery and Urology at UPMC Medical Education, and a fellowship in Minimally Invasive Urologic Surgery at UCLA. Dr. Phelan has expertise in robotics and other minimally invasive surgical procedures. His research has been published in several journals, with recent studies focusing on urological cancer management and other nephrological conditions. He holds a CMS Meaningful Use Stage 1 Certification from Epic Systems Corporation.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2002 - 2003
UPMC Medical EducationResidency, Urology, 1998 - 2002- UPMC Medical Education (Pittsburgh)Residency, Surgery, 1996 - 1998
Boston University School of MedicineClass of 1996
Certifications & Licensure
CA State Medical License 2002 - 2026
MD State Medical License 2003 - 2025
PA State Medical License 1997 - 2002
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Impact of surgical management of upper tract urothelial cancer in octogenarians: A population-based study.Shu Wang, Michael Phelan, Mohummad Minhaj Siddiqui
Current Urology. 2024-09-01 - Impact of race-based calculations of eGFR on the management of muscle invasive bladder cancer.Amir Khan, Shu Wang, Kathryn Hughes Barry, Eberechukwu Onukwugha, Michael Phelan
American Journal of Clinical and Experimental Urology. 2024-01-01 - 5 citationsProstate cancer grade downgrading at time of prostatectomy provides risk-stratification insight into future tumor behavior after prostatectomy.Shu Wang, J Ryan Russell, Max Drescher, Ashley Park, Teklu Legesse
The Prostate. 2022-12-01
Journal Articles
- Minimally Invasive Donor Nephrectomy: Current State of the ArtMichael Phelan, Philip S. Brazio, Rolf N. Barth, Langenbeck's Archives of Surgery
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
